Amy Grizzle is the assistant director of the Center for Health Outcomes and PharmacoEconomic Research. She joined the center in March 1999 after spending nearly seven years in the pharmaceutical industry.
Dr. Grizzle received her BS and PharmD from the University of Arizona College of Pharmacy and then completed a two-year pharmacoeconomic fellowship with the University of Arizona and Glaxo Inc. Following her fellowship, she joined the Global Pharmacoeconomics group at Syntex, which was later acquired by Roche, in Palo Alto, California. Her primary focus was in drug development phases I - III for disease areas such as Parkinson's disease, diabetic peripheral neuropathy, cytomegalovirus retinitis, fracture healing and benign prostatic hyperplasia.
In her position as assistant director for the center, Dr. Grizzle develops and coordinates training and educational programs and manages research projects in the areas of cost-effectiveness analysis, quality-of-life assessment, disease management and medication use evaluation. She also is charged with developing research collaborations among the center, pharmaceutical and health care companies and other centers of excellence at the University of Arizona Health Sciences.
Some of her research efforts at the center have included studying the use of pharmacoeconomic information in managed care decisionmaking, the impact of clinical pharmacy services in assisted living facilities, and the effect of treatment for posttraumatic stress disorder on economic and humanistic outcomes.